T0	KEYPHRASE-NOTYPES 0 18	Facial nerve palsy
T1	KEYPHRASE-NOTYPES 20 38	Facial nerve palsy
T2	KEYPHRASE-NOTYPES 40 43	FNP
T3	KEYPHRASE-NOTYPES 55 89	frequent neurological complication
T4	KEYPHRASE-NOTYPES 93 101	children
T5	KEYPHRASE-NOTYPES 153 166	manifestation
T6	KEYPHRASE-NOTYPES 170 182	Lyme disease
T7	KEYPHRASE-NOTYPES 187 199	large series
T8	KEYPHRASE-NOTYPES 211 216	third
T9	KEYPHRASE-NOTYPES 220 228	patients
T10	KEYPHRASE-NOTYPES 234 282	Lyme disease-associated FNP report antecedent EM
T11	KEYPHRASE-NOTYPES 291 300	tick bite
T12	KEYPHRASE-NOTYPES 316 318	EM
T13	KEYPHRASE-NOTYPES 333 337	face
T14	KEYPHRASE-NOTYPES 341 345	neck
T15	KEYPHRASE-NOTYPES 347 350	FNP
T16	KEYPHRASE-NOTYPES 371 380	side
T17	KEYPHRASE-NOTYPES 382 403	Bilateral involvement
T18	KEYPHRASE-NOTYPES 438 446	patients
T19	KEYPHRASE-NOTYPES 468 495	Lyme disease-associated FNP
T20	KEYPHRASE-NOTYPES 507 532	distinct seasonal pattern
T21	KEYPHRASE-NOTYPES 539 542	May
T22	KEYPHRASE-NOTYPES 546 554	November
T23	KEYPHRASE-NOTYPES 561 575	peak incidence
T24	KEYPHRASE-NOTYPES 583 596	summer months
T25	KEYPHRASE-NOTYPES 598 615	nEuropean studies
T26	KEYPHRASE-NOTYPES 630 651	Lyme neuroborreliosis
T27	KEYPHRASE-NOTYPES 664 676	common cause
T28	KEYPHRASE-NOTYPES 680 683	FNP
T29	KEYPHRASE-NOTYPES 687 695	children
T30	KEYPHRASE-NOTYPES 708 721	endemic areas
T31	KEYPHRASE-NOTYPES 788 796	children
T32	KEYPHRASE-NOTYPES 802 805	FNP
T33	KEYPHRASE-NOTYPES 825 841	neuroborreliosis
T34	KEYPHRASE-NOTYPES 858 867	detection
T35	KEYPHRASE-NOTYPES 871 901	CSF Bb-specific IgM antibodies
T36	KEYPHRASE-NOTYPES 915 934	Prospective studies
T37	KEYPHRASE-NOTYPES 956 966	percentage
T38	KEYPHRASE-NOTYPES 1001 1014	summer months
T39	KEYPHRASE-NOTYPES 1042 1055	adult studies
T40	KEYPHRASE-NOTYPES 1069 1087	relative frequency
T41	KEYPHRASE-NOTYPES 1091 1118	Lyme disease-associated FNP
